Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : International Nursing Services Inc, old (NURS) new (MDIX) -- Ignore unavailable to you. Want to Upgrade?

To: Mike Moran who wrote (1376)	5/24/1998 2:51:00 PM
From: Rockhill	Read Replies (1) \| Respond to of 2911

I don't think that a reverse split is what we need at this point. What we want is some institutional buyers to move into MDIX which would ultimately add stability to the stock price. The keys for MDIX, according to Mike and others, are--to finalize the sale, announce positive developments regarding the ADRX lawsuit, and announce the share buyback program. My question are: 1) What is the likelihood of institutional money coming into MDIX even if all of the above mentioned requirements were to be fulfilled? Mike, based on your conversations with your broker friend, what is it going to take to get some "safer hands" into this stock? 2) What are the chances of MDIX being able to implement a buyback; in other words, is it viable financially for MDIX to allocate 1-2 mil $ to buy back shares? 3)What is the status of the ADRX lawsuit and when is some sort of update expected from the company? 4) With MDIX patents pending and competition fierce, especially for a company that has to spend to much time with "survival issues", what are the chances of similar products being brought onto the market short term? 5) "It seems that if major industry players are as interested in MDIX as we are lead to believe, MDIX, with or without a poison pill, will probably be bought out." If MDIX is as undervalued as you say it is, Mike(based on the acquisitions of MDIX competitors), isn't it just a matter of time? 6) What is a realistic timeline for MDIX to establish itself in the industry, based on its small sales force and limited resources? Rock

To: Mike Moran who wrote (1376)	7/31/1998 3:29:00 PM
From: Arcane Lore	Respond to of 2911

<Off Topic> John, about three years ago I was sitting in the office of the President of a California healthcare technology company, doing my stuff, when in walks the one and only Rafi Kahn. ... COMMISSION CHARGES STOCKBROKERS RAFI KHAN AND TIMOTHY TYRRELL WITH STOCK MANIPULATION The Commission filed a complaint in federal district court in Los Angeles charging Rafi M. Khan with fraud for manipulating the stocks of two companies, Future Communications, Inc. (FCMI), and The L. L. Knickerbocker Co., Inc. (KNIC). From June 30 to August 30, 1993, FCMI's stock price rose from $6.50 to $27.25. Two months later, the company declared bankruptcy. From July 3 to August 11, 1995, KNIC's stock price rose from $6 to $52 per share. The complaint alleges that Khan orchestrated these price runs using a variety of manipulative practices, including acquiring substantial control of the market for each stock, executing unauthorized trades, touting wildly exaggerated earnings projections, and promoting a "short squeeze" scheme. The complaint also alleges that Timothy J. Tyrrell participated in the FCMI manipulation by, among other things, orchestrating a collusive trading arrangement with another broker. The Complaint charges Khan and Tyrrell with violating Section 17(a) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder, and seeks permanent injunctions, disgorgement of improper trading profits with prejudgment interest, and civil penalties. [SEC v. Rafi M. Khan and Timothy J. Tyrrell, Civil Action No. CV-98-6143 MMM, SHx, C.D. Cal.] (LR-15827) sec.gov